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Background: The Guardian Laryngeal Mask Airway (G-LMA) is a new silicone-based single-use extraglottic device
with the drainage port and a cuff pilot valve with pressure indicator. The aim of this study is to compare the clinical
performance of this laryngeal mask airway with ProSeal laryngeal mask airway (P-LMA).
Methods: In this prospective randomized study, we included adult patients with ASA grading I and II scheduled for
elective surgery requiring supine position under total intravenous anesthesia. The patients were randomly allocated to
two groups, 40 in each. G-LMA and P-LMA were used in groups G and P respectively. The cuff of each device was air
inflated to 60 cmH2O. The primary outcome was to compare the airway sealing pressure and the secondary outcome
was to compare the efficacy and safety of these two devices with respect to insertion success, insertion time, ease of
insertion, volume of air for cuff inflation to 60 cmH2O, intracuff pressure measurement, gastric tube insertion attempt,
gastric tube insertion time, Fiberoptic laryngeal view, and postoperative pharyngolaryngeal morbidity.
Results: The airway sealing pressure at 60cmH2O cuff pressure was significantly greater in G-LMA than P-LMA
(p = 0.04).The first successful attempt of both groups were comparable (p = 1.000). Insertion time was significantly
shorter in G-LMA than P-LMA (p < 0.0001). The first successful attempt for the gastric tube insertion in both
groups was comparable (p = 0.431). Gastric tube insertion time was less in G-LMA than in P-LMA (p < 0.0001). The
volume of air for cuff inflation to 60 cmH2O was more in G-LMA than in P-LMA (<0.0001). The intracuff pressure
measurement at 30, 60, 90 and 120 minutes were comparable (p = 0.823, 0.182, 0.870, 0.658).We did not find
differences in ease of insertion (p = 0.60); Fiber-optic positions of airway devices were comparable (p = 0.83). In
addition, blood staining (p = 1.00), sore throat and dysphagia at 1, 2 and 24 hour (p = 1.00) were comparable in
both groups.
Conclusion: The Guardian laryngeal mask airway was associated with high airway sealing pressure with a quicker
insertion of the device as well as gastric tube.
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The Guardian laryngeal mask airway (G-LMA) (Ultimate
Medical Pty Ltd, Richmond, Vic, Australia) is a new
silicone-based single–use extraglottic airway device that
forms a seal with the glottis for ventilation, and with the
hypopharynx for airway protection. It also provides a
gastric drainage port (Figure 1). In addition, it has a port
with suctioning material from the hypopharynx and a
pilot balloon valve with pressure logo (Yellow <40
cmH2O, Green 40–60 cmH2O and Red >60 cmH2O)
that indicate visual intracuff pressure (ICP) [1].This La-
ryngeal mask airway has been approved by SFDA (State
Food and Drug Administration) for clinical application.
The ProSeal laryngeal mask airway (P-LMA) (Laryngeal
Mask Company, Henley-on-Thames, UK) is a reusable,
silicone-based extraglottic airway device with a modified
cuff to improve seal and a drain tube to provide channel
for regurgitated fluid, prevention of gastric insufflation,
and insertion of gastric tube [2,3]. We hypothesized that
the differences in cuff design and airway tube results in
differing effectiveness of glottic seal for ventilation. The
aim of this study is to compare the clinical performance
of G-LMA and P-LMA, and their postoperative pharyn-
golaryngeal morbidity. The primary outcome was to
compare the airway sealing pressure (ASP) and the sec-
ondary outcome to compare the efficacy and safety of
these two devices with respect to insertion success, inser-
tion time, ease of insertion, volume of air for cuff inflation
to 60 cmH2O, intracuff pressure (ICP) measurement, gas-
tric tube insertion attempt, gastric tube insertion time,
Fiberoptic laryngeal view, and postoperative pharyngolar-
yngeal morbidity.
Methods
This study was approved by Tianjin Medical University
General Hospital, Ethic Committee of Tianjin MedicalFigure 1 Guardian laryngeal mask airway with pilot balloon valve indicatinUniversity General Hospital, (Phone: +86-22-60361044).
Approval number: IRB2013-035-01.
It was conducted according to the guidelines of the above
mentioned ethical requirements, and all patients gave writ-
ten consent prior the study. 80 adult patients (ASA I and
II) undergoing elective surgery in the supine position were
randomly and prospectively enrolled in this study. The pa-
tients were randomly allocated to two groups - Group G
where G-LMA was used and Group P where P-LMA was
used; each group had 40 patients. The randomization was
performed using sealed enveloped method from different
surgical department (Figure 2). Patients aged less than
18 years, pregnant, with known difficult airway, body
weight < 50 kg, body mass index (BMI) >35 kg/m2, cervical
spine disease, incisor distance <2.5 cm, thyromental dis-
tance <6 cm, recent history of upper respiratory tract
infection, history of gastro-esophageal reflux disease
and full stomach were excluded from the study [4-6].
(Additional file 1).
Standard monitoring devices were attached before induc-
tion of anesthesia. After pre-oxygenation for 3 min,
anesthesia was induced with intravenous injection of
midazolam 0.05 mg/kg, sufentanil 0.4 μg/kg, and propofol
2–2.5 mg/kg. The rocuronium 0.6 mg/kg was given for
neuromuscular blockade. The lungs were manually venti-
lated with oxygen via facemask for 3 min before the ran-
domized airway device was picked up and inserted. Once
the adequate depth of anesthesia was achieved, the assigned
airway device was inserted. Only size 4 airway devices were
used for adult patients weighing 50–70 kg. The insertion
technique for both devices was identical to the recom-
mended technique for laryngeal mask airway (LMA) and
included head extension, neck flexion, full deflation of the
cuff and a mid-line approach with index finger. Following
insertion, the patients’ heads were stabilized in a neutral
position. The cuff of airway device was air inflated to 60g pressure logo (Ultimate Medical Pty Ltd, Richmond, Vic, Australia).
Figure 2 Patients flow chart (G-LMA vs. P-LMA).
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cuff pressure gauge (Ambu Deutschland GmbH, Germany);
the volume of air used was recorded. The number of inser-
tion attempts was recorded. Two attempts were allowed
before device use was considered a failure. Endotracheal in-
tubation was performed when the randomized device failed.
The insertion was scored as (1, insertion of device at first
attempt without resistance; 2, insertion of device at first at-
tempt with resistance; 3, insertion of device successful at
second attempt; 4, insertion failed at second attempt) [7]. If
a manipulation was required to achieve an effective airway,
it was recorded as either ‘yes’ or ‘no’ and maneuvers re-
quired were recorded. The time between the picking up of
the device and obtaining an effective airway was recorded.
Effective ventilation was judged by bilateral symmetrical
chest movement during manual ventilation, square wave on
capnograph, no audible leak from the mouth and lack of
gastric insufflation [8]. The device was fixed by taping the
tube over the chin.
Once the effective airway was obtained, ICP was set at
60 cmH2O, and ASP determined by closing the expiratory
valve of circle system at a fixed gas flow of 3 l/min. The
airway pressure (maximum allowed, 40 cmH2O) at which
an equilibrium was reached was recorded. The airway leak
was detected by an audible sound of gas escaping from the
mouth heard by listening closely to patient’s mouth [7].
ICP was measured at 30, 60, 90 and 120 minutes, and 60
cmH2O was maintained throughout the surgery.
A 14-French size gastric tube was used for both groups.
A well-lubricated gastric tube was inserted into the stom-
ach through gastric port of airway device. Correct place-
ment was assessed by aspiration of gastric content or
detection of injected air by epigastric auscultation [9].Thetime taken for correct placement was recorded (picking up
the gastric tube until confirmation of placement). Failure
was defined as inability to advance the gastric tube within
two attempts. The anatomic position of airway devices was
determined by passing flexible bronchoscope to a position
just proximal to the end of the airway tube and scoring the
view (1, Clear view of vocal cord; 2, Only arytenoids visible;
3, Only epiglottis visible; 4, No laryngeal structures visible)
[3]. The patients’ lungs were ventilated with a tidal volume
of 8 ml/kg, an inspiratory:expiratory ratio of 1:2, and the re-
spiratory rate was adjusted according to an end-tidal CO2
of 35–40 mmHg with a fresh gas flow of 1.5 l/min. The
anesthesia was maintained with continuous infusion of pro-
pofol 4–6 m/kg/h and remifentanil 0.1-0.3 μg/kg/min. A
muscle relaxant was given in order to provide surgical re-
laxation. At the end of surgical procedure, anesthesia was
discontinued. The airway device was removed when the pa-
tient was awake and obeyed verbal command. Following
the removal of the device, it was checked for blood stained
secretion and the observation was recorded. An independ-
ent staff member was solely responsible for recording
postoperative pharyngolaryngeal morbidity (sore throat,
dysphagia and dysphonia) at 1, 2 and 24 hours after sur-
gery. The predetermined definition of postoperative phar-
yngolaryngeal morbidity for assessment: sore throat was
defined as “constant pain or discomfort in the throat inde-
pendent of swallowing”; dysphagia was defined as “diffi-
culty or pain provoked by swallowing”; dysphonia was
defined as “difficulty or pain on speaking”[10].
Statistics
The primary outcome is the airway sealing pressure. The
sample size was calculated to be 37 patients per group
Pajiyar et al. BMC Anesthesiology  (2015) 15:69 Page 4 of 7based on our study with the power of the test (1-beta)
80% and alpha level of 0.05 (for two-sided test). This
gives an estimated difference of 2 cmH2O between
groups, where (mean ± SD) of airway sealing pressure of
GLMA was (32.36 ± 4.93 cmH2O) and PLMA was
(29.41 ± 4.33 cmH2O) – as determined by an intracuff
pressure of 60 cmH2O. In the case of any potential
dropouts and guided by the above calculations, an opti-
mal sample size of 40 patients in each group was chosen.
The SPSS 17.0 statistical software system was used for
statistical analysis. Device insertion time, volume of air
for cuff inflation to 60 cmH2O, airway sealing pressure,
gastric tube insertion time and ICP measurement were
compared using Student t-test and Mann–Whitney test.
Success rate of first insertion attempt, ease of insertion
score, gastric tube insertion attempt, fiberoptic view and
post-operative pharyngolaryngeal morbidity was com-
pared using Chi-square test and Fisher exact test. A P
value <0.05 was considered statistically significant.
Results
The values are presented as mean ± SD or as numbers or
as the number (%). There were no significant differences
between the demographic profiles of patients and surgery
types in the both groups [Table 1]. The results of airway
sealing pressure, volume of air for cuff inflation to 60
cmH2O, ICP measurement, blood staining and postopera-
tive pharyngolaryngeal morbidity are shown in Table 2.
The results of successful insertion attempts, device inser-
tion time, ease of insertion, successful gastric tube inser-
tion attempt, gastric tube insertion time and fiberoptic
position of airway devices are shown in Table 3.
The ASP (at 60 cmH2O) was significantly higher in G-
LMA than in P-LMA (p = 0.04) (Figure 3). The volume
of air for cuff inflation to 60 cmH2O was significantly
higher in G-LMA (22.60 ± 3.27 ml) than in P-LMATable 1 Demographic characteristics and type of surgery
performed




Age (years) 45.20 ± 14.78 45.75 ± 13.58
Sex (M/F) 8/32 12/28
Weight (kg) 59.75 ± 4.72 61.65 ± 8.95
Height (cm) 160.30 ± 4.11 162.20 ± 4.86
Body Mass Index
(BMI) (kg/m2)





General surgery 4 6
P-LMA: ProSeal laryngeal mask airway; G-LMA: Guardian laryngeal mask airway.(13.90 ± 1.19 ml) (p < 0.0001).The device insertion time
for G-LMA (13.20 ± 1.82 seconds) was less than that of
P-LMA (15.95 ± 1.84 seconds) (p < 0.0001). The gastric
tube insertion time for G-LMA (10.05 ± 1.35 seconds) was
less than that of P-LMA (13.75 ± 1.74 seconds) (p < 0.0001).
We found no differences in successful insertion attempt
(first attempt: G-LMA, 97.5%; P-LMA, 95%), ease of inser-
tion (G-LMA, grade 1 = 30/40; P-LMA, grade 1 = 28/40),
manipulation required to achieve effective airway, success-
ful gastric tube insertion attempt (over all 100% within two
attempt), ICP measurement, fiber-optic position of airway,
blood staining (G-LMA, 20%; P-LMA, 22.5%) and postop-
erative pharyngolaryngeal morbidity (sore throat, dysphagia
and dysphonia) at 1, 2, 24 hours after the surgery.
The parameters such as blood pressure, heart rate, end-
tidal CO2, SpO2 were comparable between the two groups
and were found within normal limit during the periopera-
tive period. The hemodynamic and respiratory responses
between the groups were found within normal limit in the
post anesthetic care unit (PACU). Vomiting, regurgitation
of gastric content, and minor trauma like lip/teeth/gums
were not observed in both groups of patients.
Discussion
This prospective randomized study was designed to
compare the clinical performance of two laryngeal mask
airways (P-LMA and G-LMA) and their postoperative
pharyngolaryngeal morbidity. We found that the G-
LMA had higher ASP with a short insertion time of the
device as well as gastric tube as compared to P-LMA.
The ASP was measured as a primary outcome meas-
ure. It was measured when both the devices had air in-
flated to 60 cmH2O cuff pressure. We found that the
mean ASP was higher for G-LMA than P-LMA. This
may be due to differences in the shape and size of the
cuff or single softer curved airway tube allowing full
depth of insertion. High ASP indicates airway protection,
feasibility of positive pressure ventilation and successful
placement of LMA devices [8]. Verghese et al. [11] re-
ported that at 60 cmH2O cuff pressure, ASP was identi-
cal while comparing PLMA and Supreme LMA (SLMA),
in anesthetized female patients using neuromuscular
blockade. Hosten et al. [12] demonstrated that in adult
patients, SLMA had leak pressure similar to P-LMA.
Seet et al. and Eschertzhuber et al. [13,14] reported that
the ASP was higher for P-LMA than SLMA. Hosten
et al. [15] claimed that the SLMA and P-LMA had simi-
lar leak pressure during laparoscopic cholecystectomy,
suggesting G-LMA as a suitable airway device in laparo-
scopic cholecystectomy. Direct comparative study will
be required to confirm this.
The cuffs of all devices were inflated to prefixed pres-
sure (rather than a volume). To achieve 60 cmH2O, the
P-LMA cuff requires larger volume of air than the
Table 3 Device insertion characteristics, gastric tube insertion characteristics and fiber-optic view
Variables Group P (P-LMA) Group G (G-LMA) P value
(n = 40) (n = 40)
Successful insertion attempt
First 38 (95%) 39 (97.5%) 1.000
Second 2 (5%) 1 (2.5%)
Over all 100% 100%






Manipulation 6/40 4/40 0.373
Maneuvers 6/40 4/40 0.373
Successful gastric tube insertion attempt
First 35 (87.5%) 38 (95%) 0.431
Second 5 (12.5%) 2 (5%)
Overall 40 (100%) 40 (100%)
Gastric tube insertion time, seconds 13.75 ± 1.74** 10.05 ± 1.35** <0.0001**
Fiber-optic view
(1/2/3/4) 14/21/3/2 17/20/2/1 0.836
**P < 0.01, *p < 0.05, P-LMA: ProSeal laryngeal mask airway; G-LMA: Guardia laryngeal mask airway.
Table 2 Airway sealing pressure, cuff volume, intracuff pressure and pharyngolaryngeal morbidity





Volume of air for cuff inflation to 60 cmH2O, ml 13.90 ± 1.19** 22.60 ± 3.27** <0.0001**
Airway sealing pressure, cmH2O 29.41 ± 4.33* 32.36 ± 4.93* 0.04*
Intracuff pressure measurement, cmH2O
30 min 58.83 ± 1.14 58.90 ± 1.15 0.823
60 min 58.67 ± 1.09 58.27 ± 1.20 0.182
90 min 58.40 ± 1.23 58.33 ± 1.35 0.870
120 min 58.27 ± 1.09 58.44 ± 1.03 0.658
Blood staining on removal of device 9/40 (22.5%) 8/40 (20%) 1.000
Postoperative pharyngolaryngeal morbidity
Sore throat
1 h 7/40 (17.5%) 6/40 (15%) 1.000
2 h 7/40 6/40
24 h 0 0
Dysphagia
1 h 5/40 (12.5%) 4/40 (10%) 1.000
2 h 5/40 4/40
24 h 0 0
Dysphonia
1 h 0 0
2 h 0 0
24 h 0 0
**P < 0.01, *p < 0.05, P-LMA: ProSeal laryngeal mask airway; G-LMA: Guardian laryngeal mask airway; h: hours, min: minutes, ml: milliliter.
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Figure 3 Comparison of airway sealing pressure in two groups (G-
LMA vs. P-LMA). Results are given as means ± SD,*p < 0.05.
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device may increase seal pressure by allowing the cuff
wall to match the shape of pharynx and larynx [16]. On
the contrary, we obtained the volume of air which was
significantly more in G-LMA than in the P-LMA. In-
stead of larger static cuff volume, the difference in vol-
ume required for obtaining target pressure was small.
Small increases in the cuff volume caused marked in-
creases in ICP [3]. This may be due to differences in the
shape of the cuff and we assumed the cuff of G-LMA
closely matches with the shape of pharynx and larynx,
which might account for improved sealing pressure and
low compliance during further inflation. We recommend
a further study to confirm this.
The ICP was measured at 30, 60, 90 and 120 minutes
and no difference was found between the groups. 60
cmH2O cuff pressure was maintained during surgery to
eliminate the potential effect of pressure. As ICP of
LMA devices increases, pharyngeal mucosal perfusion is
progressively decreased, which results in postoperative
pharyngolaryngeal adverse events [17]. Therefore, limit-
ing cuff pressures of LMA devices can reduce postopera-
tive pharyngolaryngeal adverse events [18-20]. Seet
et al.[21] demonstrated that the use of manometry to
limit ICP of LMA devices from 112 mmHg to < 44 mmHg
(60 cmH2O) reduced pharyngolaryngeal adverse events in
ambulatory surgical patients, but 60 cmH2O was still the
higher limit in terms of airway perfusion pressure.We
found no difference in postoperative pharyngolaryngeal
morbidity (sore throat, dysphagia and dysphonia) at 1, 2
and 24 hours between two groups after the surgery. The
cause might be associated with postoperative analgesic,
which was not recorded in our study.
We found no differences in device insertion success,
ease of insertion, gastric tube insertion success, and
fiberoptic assessment of airway devices. We found that
LMA insertion time was less in G-LMA than in P-LMA.As compared to P-LMA, G-LMA has single, softer
curved airway tube that may be easy to insert. The
drainage tube of P-LMA runs laterally with the ventila-
tory side of the airway device and later towards the tip
of P-LMA and ends in the midline. However, the drain-
age tube of G-LMA is directly posterior to the ventila-
tory side and runs through the midline, and opens at the
distal end of the cuff. We believe that an improved
drainage tube design may explain the shortened inser-
tion time of the gastric tube placement in G-LMA. The
easy gastric access may be the additional safety benefit
for the use of G-LMA to prevent aspiration.
The G-LMA has two extra features that are not present
in the P-LMA: the hypopharyngeal port and visibly in-
built ICP monitor. Formally, the efficacy of these features
was not tested in our study but the ICP is roughly
matched with the hand held pressure measuring device.
Our study has some limitations. We only used size-4
devices in adult patients with neuromuscular blockade;
however, it can be presumed that same results would be
obtained in patients who have not received neuromuscu-
lar blockade. Lastly, some of our data were not blinded,
thus causing potential source of bias.
Conclusion
We concluded that the G-LMA was associated with high
airway sealing pressure during controlled ventilation and
a quicker insertion of the device and gastric tube as
compared to P-LMA in anesthetized adult patients who
received neuromuscular drugs. The device insertion suc-
cess, ease of insertion and postoperative pharyngolaryn-
geal morbidity were comparable. We recommend
further study in multicenter, randomized trial with large
number of patients.
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Abbreviation
ASP: Airway sealing pressure; G-LMA: Guardian laryngeal mask airway;
ICP: Intracuff pressure; LMA: Laryngeal mask airway; PACU: Post Anaesthetic
Care Unit; P-LMA: ProSeal laryngeal mask airway; SLMA: Supreme laryngeal
mask airway.
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